GenRx Cisatracurium cisatracurium (as besilate) 20 mg / 10 mL solution for injection ampoule

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

cisatracurium besilate, Quantity: 2.68 mg/mL (Equivalent: cisatracurium, Qty 2 mg/mL)

Inapatikana kutoka:

Arrotex Pharmaceuticals Pty Ltd

INN (Jina la Kimataifa):

cisatracurium besilate

Dawa fomu:

Injection, solution

Tungo:

Excipient Ingredients: benzenesulfonic acid; water for injections

Njia ya uendeshaji:

Intravenous, Intravenous Infusion

Vitengo katika mfuko:

5

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. It is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Bidhaa muhtasari:

Visual Identification: Colourless, transparent solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2016-04-12